Ascertain Lands Major AI Automation Deal With Nation’s Largest Cardiology Network

New updates have been reported about Ascertain.

Ascertain has signed a strategic partnership with Cardiovascular Associates of America (CVAUSA), the country’s largest cardiovascular network, to deploy its agentic AI platform across more than 460 physicians and 290 advanced practice providers in over 100 clinic locations across eight states. The agreement positions Ascertain at the core of CVAUSA’s operational infrastructure, automating prior authorizations and other high-friction administrative tasks tied to hundreds of thousands of annual office visits, imaging studies, and interventional procedures for more than 1.3 million patients. By replacing manual data entry, documentation assembly, and payer communications with touchless automation, Ascertain aims to increase throughput, reduce administrative bottlenecks that delay cardiac care, and lower operating costs for one of the most complex and procedure-heavy specialties in healthcare.

For Ascertain, this deployment is a significant proof point for its agentic AI strategy in specialty care and a scaled reference account in cardiovascular medicine, an area where prior authorization and payer documentation requirements are especially onerous. CEO Mark Michalski, MD, framed the deal as aligned with the future of specialty care—physician-led, value-focused, and innovation-driven—and underscored the potential to convert saved administrative hours into additional clinical capacity at a time when nearly half of U.S. adults live with heart or vascular disease. CVAUSA’s leadership highlighted that the partnership is intended to tackle prior authorization delays at scale and strengthen the network’s operational excellence. Founded in partnership with Northwell Health and Aegis Ventures and backed by Deerfield Management, Ascertain can leverage this implementation as a commercial and clinical validation milestone that may support further adoption with other large provider networks and payers.